Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.42 USD | -2.89% | +5.64% | +38.90% |
09/05 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
07/05 | Piper Sandler Adjusts Price Target on Crinetics Pharmaceuticals to $97 From $56, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.90% | 3.89B | |
+23.37% | 47.02B | |
+48.83% | 41.86B | |
-0.94% | 41.76B | |
-5.86% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Crinetics Pharmaceuticals Insider Sold Shares Worth $449,793, According to a Recent SEC Filing